Citations (117)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Francesco Marchi, Chiara Kessler, Daniela Distefano, Lodovico Terzi di Bergamo, Luca Fumagalli, Manuela Averaimo, Emanuele Crupi, Fabio Bergamini, Giorgia Melli, Georg Stussi, Davide Rossi, Claudio Gobbi, Paolo Ripellino, Emanuele Pravatà, Dominique E. Kuhlen, Christoph Röcken, Pietro Scarone, Bernhard Gerber & Adalgisa Condoluci. (2023) Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosis. Amyloid 30:4, pages 416-423.
Read now
Read now
Masashi Uehara, Shugo Kuraishi, Shota Ikegami, Hiroki Oba, Takashi Takizawa, Ryo Munakata, Terue Hatakenaka, Takayuki Kamanaka, Yoshinari Miyaoka, Yoshiki Sekijima & Jun Takahashi. (2023) Cervical myelopathy due to amyloid deposition with accompanying cardiac abnormalities. The Journal of Spinal Cord Medicine 46:4, pages 697-701.
Read now
Read now
Aikaterini Papagianni, Sandra Ihne, Daniel Zeller, Caroline Morbach, Nurcan Üçeyler & Claudia Sommer. (2022) Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type. Amyloid 29:1, pages 14-22.
Read now
Read now
Amandeep Godara, Ron I. Riesenburger, Diana X. Zhang, Cindy Varga, Teresa Fogaren, Nauman S. Siddiqui, Anthony Yu, Andy Wang, Michael Mastroianni, Richard Dowd, Tara J. Nail, Ellen D. McPhail, Paul J. Kurtin, Jason D. Theis, Denis Toskic, Knarik Arkun, Monika Pilichowska, James Kryzanski, Ayan R. Patel & Raymond Comenzo. (2021) Association between spinal stenosis and wild-type ATTR amyloidosis. Amyloid 28:4, pages 226-233.
Read now
Read now
Masayoshi Tasaki, Masamitsu Okada, Akihiro Yanagisawa, Toshiya Nomura, Hiroaki Matsushita, Akihiko Ueda, Yasuteru Inoue, Teruaki Masuda, Yohei Misumi, Taro Yamashita, Takayuki Nakamura, Takeshi Miyamoto, Konen Obayashi, Yukio Ando & Mitsuharu Ueda. (2021) Apolipoprotein AI amyloid deposits in the ligamentum flavum in patients with lumbar spinal canal stenosis. Amyloid 28:2, pages 107-112.
Read now
Read now
Sophie Bartier, Diane Bodez, Mounira Kharoubi, Florence Canouï-Poitrine, Véronique Chatelin, Carole Henrion, André Coste, Thibaud Damy & Emilie Béquignon. (2019) Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study. Amyloid 26:4, pages 216-224.
Read now
Read now
Jonah Rubin, Julissa Alvarez, Sergio Teruya, Adam Castano, Ronald A. Lehman, Mark Weidenbaum, Jeffrey A. Geller, Stephen Helmke & Mathew S. Maurer. (2017) Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?. Amyloid 24:4, pages 224-228.
Read now
Read now
Arne Andersson. (2017) A milestone reached?. Upsala Journal of Medical Sciences 122:4, pages 205-206.
Read now
Read now
Kourosh Rezania, Peter Pytel, W. Edward Highsmith & Patrik Gabikian. (2017) Cervicomedullary compression as the main manifestation of wild-type transthyretin amyloidosis. Amyloid 24:2, pages 133-134.
Read now
Read now
Emilie Béquignon, Aziz Guellich, Sophie Bartier, Marc Raynal, Virginie Prulière-Escabasse, Florence Canouï-Poitrine, André Coste & Thibaud Damy. (2017) How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot study. Amyloid 24:2, pages 96-100.
Read now
Read now
Michitaka Nakagawa, Yoshiki Sekijima, Masahide Yazaki, Kana Tojo, Tsuneaki Yoshinaga, Tadashi Doden, Jun Koyama, Shin Yanagisawa & Shu-Ichi Ikeda. (2016) Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis. Amyloid 23:1, pages 58-63.
Read now
Read now
Björn Pilebro, Ole B. Suhr, Ulf Näslund, Per Westermark, Per Lindqvist & Torbjörn Sundström. (2016) 99mTc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis. Upsala Journal of Medical Sciences 121:1, pages 17-24.
Read now
Read now
Arne Andersson & Joey Lau Börjesson. (2015) Operating in an era of impact factor mania. Upsala Journal of Medical Sciences 120:2, pages 124-131.
Read now
Read now
Articles from other publishers (104)
Michael A. Smith & Neil G. Feinglass. (2024) Perioperative implications of amyloidosis and amyloid cardiomyopathy: A review for anesthesiologists. Journal of Clinical Anesthesia 92, pages 111271.
Crossref
Crossref
Ana Moya, Clara L. Oeste, Monika Beles, Sofie Verstreken, Riet Dierckx, Ward Heggermont, Jozef Bartunek, Eline Bogaerts, Imke Masuy, Dries Hens, Dario Bertolone & Marc Vanderheyden. (2023) Detection of transthyretin amyloid cardiomyopathy by automated data extraction from electronic health records. ESC Heart Failure 10:6, pages 3483-3492.
Crossref
Crossref
Kazuya Maeda, Kazuki Sugimoto, Masayoshi Tasaki, Takuya Taniwaki, Takahiro Arima, Yuto Shibata, Makoto Tateyama, Tatsuki Karasugi, Takanao Sueyoshi, Tetsuro Masuda, Yusuke Uehara, Takuya Tokunaga, Satoshi Hisanaga, Masaki Yugami, Ryuji Yonemitsu, Katsumasa Ideo, Kozo Matsushita, Yuko Fukuma, Masaru Uragami, Junki Kawakami, Naoto Yoshimura, Kosei Takata, Masaki Shimada, Shuntaro Tanimura, Hideto Matsunaga, Yuki Kai, Shu Takata, Ryuta Kubo, Rui Tajiri, Fuka Homma, Xiao Tian, Mitsuharu Ueda, Takayuki Nakamura & Takeshi Miyamoto. (2023) Transthyretin amyloid deposition in ligamentum flavum (LF) is significantly correlated with LF and epidural fat hypertrophy in patients with lumbar spinal stenosis. Scientific Reports 13:1.
Crossref
Crossref
Martín Negreira Caamaño, Marco Aurelio Ramírez Huaranga, Ana María García Vicente, Miguel Ángel Rienda Moreno, David Castro Corredor & Jesús Piqueras Flores. (2023) «Banderas rojas» de amiloidosis cardiaca en pacientes con estenosis de canal lumbar e hipertrofia de ligamento amarillo. Medicina Clínica.
Crossref
Crossref
Emre Aldinc, Courtney Campbell, Finn Gustafsson, Abigail Beveridge, Richard Macey, Laura Marr, Catherine Summers & Dafang Zhang. (2023) Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review. BMC Musculoskeletal Disorders 24:1.
Crossref
Crossref
Andy Y. Wang, Jainith Patel, Matthew Kanter, Michelle Olmos, Mathew S. Maurer, Ellen D. McPhail, Ayan R. Patel, Knarik Arkun, James Kryzanski & Ron I. Riesenburger. (2023) The Emerging Significance of Amyloid Deposits in the Ligamentum Flavum of Spinal Stenosis Patients: A Review. World Neurosurgery 177, pages 88-97.
Crossref
Crossref
Martín Negreira-Caamaño, Marco Aurelio Ramírez-Huaranga, Ana María García-Vicente, Miguel Ángel Rienda-Moreno, Paula Otero-Fernández, David Castro-Corredor, Ángel E Plasencia-Enzaíne, Jorge Martínez-Del Río, Emilio Blanco-López & Jesús Piqueras-Flores. (2023) Cardiac amyloidosis in patients with spinal stenosis and yellow ligament hypertrophy. International Journal of Cardiology, pages 131301.
Crossref
Crossref
Michelle M. Kittleson, Frederick L. Ruberg, Amrut V. Ambardekar, Thomas H. Brannagan, Richard K. Cheng, John O. Clarke, Laura M. Dember, Janell Grazzini Frantz, Ray E. Hershberger, Mathew S. Maurer, Jose Nativi-Nicolau, Vaishali Sanchorawala & Farooq H. Sheikh. (2023) 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis. Journal of the American College of Cardiology 81:11, pages 1076-1126.
Crossref
Crossref
Alyssa Basdavanos, Mathew S. Maurer, Lauren Ives, Kathleen Derwin, Eric T. Ricchetti, William Seitz & Mazen Hanna. (2023) Prevalence of Orthopedic Manifestations in Patients With Cardiac Amyloidosis With a Focus on Shoulder Pathologies. The American Journal of Cardiology 190, pages 67-74.
Crossref
Crossref
Richard Wlodarski, Kaitlin Seibert, Naoum P. Issa, Bill O'Brien‐Penney, Betty Soliven, Nitasha Sarswat, Daniel Appelbaum & Kourosh Rezania. (2022)
99m
Technetium‐pyrophosphate bone scan: A potential biomarker for the burden of transthyretin amyloidosis in skeletal muscle: A preliminary study
. Muscle & Nerve 67:2, pages 111-116.
Crossref
Crossref
Bernardo Couto Neto & Liszt Palmeira de Oliveira. 2023. Amyloidosis and Fabry Disease. Amyloidosis and Fabry Disease
129
135
.
Mario Nuvolone, Maria Girelli & Giampaolo Merlini. (2022) Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy. International Journal of Molecular Sciences 23:24, pages 16145.
Crossref
Crossref
Trejeeve Martyn, Andres Carmona Rubio, Jerry D. Estep & Mazen Hanna. (2022) Opportunities for Earlier Diagnosis and Treatment of Cardiac Amyloidosis. Methodist DeBakey Cardiovascular Journal 18:5, pages 27-39.
Crossref
Crossref
Nicole Cyrille‐Superville. (2022) Analysis of lumbar spine stenosis for identification of amyloid. Journal of the American Geriatrics Society 70:12, pages 3356-3358.
Crossref
Crossref
Mathew S. Maurer, Dia Smiley, Eli Simsolo, Fabrizio Remotti, Angela Bustamante, Sergio Teruya, Stephen Helmke, Andrew J. Einstein, Ronald Lehman, Jon T. Giles, Jeffery W. Kelly, Felix Tsai, William S. Blaner, Pierre‐Jacques Brun, Ron I. Riesenburger, James Kryzanski, Cindy Varga & Ayan R. Patel. (2022) Analysis of lumbar spine stenosis specimens for identification of amyloid. Journal of the American Geriatrics Society 70:12, pages 3538-3548.
Crossref
Crossref
Yutaka Yabe, Yoshihiro Hagiwara, Masahiro Tsuchiya, Takashi Minowa, Taro Takemura, Shinya Hattori, Shinichirou Yoshida, Takahiro Onoki & Keisuke Ishikawa. (2022) Comparative proteome analysis of the ligamentum flavum of patients with lumbar spinal canal stenosis. JOR SPINE 5:4.
Crossref
Crossref
Andy Y. WangMatthew KanterMichelle OlmosEllen D. McPhail, Mina G. SafainJames KryzanskiKnarik Arkun & Ron I. Riesenburger. (2022) Lumbar stenosis due to wild-type transthyretin amyloid–induced thickening of the ligamentum flavum: a separate etiology from degeneration of intervertebral discs?. Journal of Neurosurgery: Spine 37:5, pages 687-693.
Crossref
Crossref
Su Shen Lim, Ling Kuo, Fu-Pang Chang, Chun-Chin Chang & Wen-Chung Yu. (2022) Prompt diagnosis of a wild-type transthyretin cardiac amyloidosis: Role of multimodality imaging. Journal of the Chinese Medical Association 85:11, pages 1101-1105.
Crossref
Crossref
Dia A. Smiley, Carlos M. Rodriguez & Mathew S. Maurer. (2022) Transthyretin Cardiac Amyloidosis. Cardiology Clinics 40:4, pages 541-558.
Crossref
Crossref
Marcus A. C. Williams, Bairavi Shankar, Joban Vaishnav & Mark J. Ranek. (2022) Current and potential therapeutic strategies for transthyretin cardiac amyloidosis. Frontiers in Drug Discovery 2.
Crossref
Crossref
Andy Y. Wang, Harleen Saini, Joseph N. Tingen, Vaishnavi Sharma, Alexandra Flores, Diang Liu, Michelle Olmos, Ellen D. McPhail, Mina G. Safain, James Kryzanski, Knarik Arkun & Ron I. Riesenburger. (2022) The Relationship Between Wild-Type Transthyretin Amyloid Load and Ligamentum Flavum Thickness in Lumbar Stenosis Patients. World Neurosurgery 164, pages e113-e118.
Crossref
Crossref
Trejeeve Martyn, Joshua Saef, Muzna Hussain, Lauren Ives, Alan Kiang, Jerry D. Estep, Patrick Collier, Randall C. Starling, Paul C. Cremer, W.H. Wilson Tang, Mazen Hanna & Wael A. Jaber. (2022) The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era. Journal of Cardiac Failure.
Crossref
Crossref
Mustafa Al Yaseen, Haider Al Zahid & Sawsan Al-Haroon. (2022) Amyloid Deposits in the Ligamentum Flavum Related to Lumbar Spinal Canal Stenosis and Lumbar Disc Degeneration. Cureus.
Crossref
Crossref
Katrine Bay, Finn Gustafsson, Michael Maiborg, Anne Bagger‐Bahnsen, Anne Mette Strand, Trine Pilgaard & Steen Hvitfeldt Poulsen. (2022) Suspicion, screening, and diagnosis of wild‐type transthyretin amyloid cardiomyopathy: a systematic literature review. ESC Heart Failure 9:3, pages 1524-1541.
Crossref
Crossref
Paul A. HeidenreichBiykem BozkurtDavid AguilarLarry A. AllenJoni J. ByunMonica M. ColvinAnita DeswalMark H. DraznerShannon M. DunlayLinda R. EversJames C. FangSavitri E. FedsonGregg C. FonarowSalim S. HayekAdrian F. HernandezPrateeti KhazanieMichelle M. KittlesonChristopher S. LeeMark S. LinkCarmelo A. MilanoLorraine C. NnachetaAlexander T. SandhuLynne Warner StevensonOrly VardenyAmanda R. VestClyde W. Yancy. (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145:18.
Crossref
Crossref
Paul A. HeidenreichBiykem BozkurtDavid AguilarLarry A. AllenJoni J. ByunMonica M. ColvinAnita DeswalMark H. DraznerShannon M. DunlayLinda R. EversJames C. FangSavitri E. FedsonGregg C. FonarowSalim S. HayekAdrian F. HernandezPrateeti KhazanieMichelle M. KittlesonChristopher S. LeeMark S. LinkCarmelo A. MilanoLorraine C. NnachetaAlexander T. SandhuLynne Warner StevensonOrly VardenyAmanda R. VestClyde W. Yancy. (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145:18.
Crossref
Crossref
Paul A. Heidenreich, Biykem Bozkurt, David Aguilar, Larry A. Allen, Joni J. Byun, Monica M. Colvin, Anita Deswal, Mark H. Drazner, Shannon M. Dunlay, Linda R. Evers, James C. Fang, Savitri E. Fedson, Gregg C. Fonarow, Salim S. Hayek, Adrian F. Hernandez, Prateeti Khazanie, Michelle M. Kittleson, Christopher S. Lee, Mark S. Link, Carmelo A. Milano, Lorraine C. Nnacheta, Alexander T. Sandhu, Lynne Warner Stevenson, Orly Vardeny, Amanda R. Vest & Clyde W. Yancy. (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology 79:17, pages e263-e421.
Crossref
Crossref
Paul A. Heidenreich, Biykem Bozkurt, David Aguilar, Larry A. Allen, Joni J. Byun, Monica M. Colvin, Anita Deswal, Mark H. Drazner, Shannon M. Dunlay, Linda R. Evers, James C. Fang, Savitri E. Fedson, Gregg C. Fonarow, Salim S. Hayek, Adrian F. Hernandez, Prateeti Khazanie, Michelle M. Kittleson, Christopher S. Lee, Mark S. Link, Carmelo A. Milano, Lorraine C. Nnacheta, Alexander T. Sandhu, Lynne Warner Stevenson, Orly Vardeny, Amanda R. Vest & Clyde W. Yancy. (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary. Journal of the American College of Cardiology 79:17, pages 1757-1780.
Crossref
Crossref
PAUL A. Heidenreich, BIYKEM BOZKURT, DAVID AGUILAR, LARRY A. ALLEN, JONI-J. BYUN, MONICA M. COLVIN, ANITA DESWAL, MARK H. DRAZNER, SHANNON M. DUNLAY, LINDA R. EVERS, JAMES C. FANG, SAVITRI E. FEDSON, GREGG C. FONAROW, SALIM S. HAYEK, ADRIAN F. HERNANDEZ, PRATEETI KHAZANIE, MICHELLE M. KITTLESON, CHRISTOPHER S. LEE, MARK S. LINK, CARMELO A. MILANO, LORRAINE C. NNACHETA, ALEXANDER T. SANDHU, LYNNE WARNER STEVENSON, ORLY VARDENY, AMANDA R. VEST & CLYDE W. YANCY. (2022) 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: Executive Summary. Journal of Cardiac Failure 28:5, pages 810-830.
Crossref
Crossref
Roxana Cristina Rimbas, Anca Balinisteanu, Stefania Lucia Magda, Simona Ionela Visoiu, Andrea Olivia Ciobanu, Elena Beganu, Alina Ioana Nicula & Dragos Vinereanu. (2022) New Advanced Imaging Parameters and Biomarkers—A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy. Journal of Clinical Medicine 11:9, pages 2360.
Crossref
Crossref
Priyanka T. Bhattacharya, Mathew S. Maurer & Dia A. Smiley. (2022) Amyloid Cardiomyopathy in Older Adults. Current Geriatrics Reports 11:1, pages 1-9.
Crossref
Crossref
Dan Ruan & Long Sun. (2021) Diagnostic efficacy of bone scintigraphy in transthyretin cardiac amyloidosis: an updated systematic review and Bayesian bivariate meta-analysis. Clinical and Translational Imaging 10:1, pages 85-98.
Crossref
Crossref
Monica Alcantara, Michelle M. Mezei, Steven K. Baker, Ari Breiner, Priya Dhawan, Amanda Fiander, Nowell M. Fine, Christopher Hahn, Hans D. Katzberg, Shahin Khayambashi, Rami Massie, Genevieve Matte, Brendan Putko, Zaeem Siddiqi, Diego Delgado & Vera Bril. (2021) Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 49:1, pages 7-18.
Crossref
Crossref
Andy Y. Wang, Vaishnavi Sharma, Harleen Saini, Joseph N. Tingen, Alexandra Flores, Diang Liu, Mina G. Safain, James Kryzanski, Ellen D. McPhail, Knarik Arkun & Ron I. Riesenburger. (2022) Machine Learning Quantification of Amyloid Deposits in Histological Images of Ligamentum Flavum. Journal of Pathology Informatics 13, pages 100013.
Crossref
Crossref
Michele Lioncino, Emanuele Monda, Giuseppe Palmiero, Martina Caiazza, Erica Vetrano, Marta Rubino, Augusto Esposito, Gemma Salerno, Francesca Dongiglio, Barbara D’Onofrio, Federica Verrillo, Giuseppe Cerciello, Fiore Manganelli, Giuseppe Pacileo, Eduardo Bossone, Paolo Golino, Paolo Calabrò & Giuseppe Limongelli. (2022) Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis. Heart Failure Clinics 18:1, pages 73-87.
Crossref
Crossref
Thomas Bardin, Jean-Denis Laredo & Sandra Guignard. 2022. L'actualité Rhumatologique 2022. L'actualité Rhumatologique 2022
45
52
.
S. S. Nikitin, S. N. Bardakov, N. A. Suponeva, I. V. Zhirov, T. A. Adyan, D. A. Grishina & R. V. Deev. (2021) Phenotypic heterogeneity and diagnostic features of transthyretin amyloidosis with polyneuropathy. Neuromuscular Diseases 11:3, pages 12-36.
Crossref
Crossref
Caio Rebouças Fonseca Cafezeiro, Aristoteles Comte de AlencarNetoNeto, Bruno Vaz Kerges Bueno, João Henrique Rissato, André Luiz Dabarian, Viviane Tiemi Hotta & Fábio Fernandes. (2021) Familial Transthyretin Cardiac Amyloidosis with Homozygous Val122Ile Mutation Mimicking Hypertrophic Cardiomyopathy. ABC: Heart Failure & Cardiomyopathy 1:2, pages 157-160.
Crossref
Crossref
Haruki Koike, Takahiro Okumura, Toyoaki Murohara & Masahisa Katsuno. (2021) Multidisciplinary Approaches for Transthyretin Amyloidosis. Cardiology and Therapy 10:2, pages 289-311.
Crossref
Crossref
Abdulaziz Joury, Tripti Gupta & Selim R. Krim. (2021) Cardiac Amyloidosis: Presentations, Diagnostic Work-up and Collaborative Approach for Comprehensive Clinical Management. Current Problems in Cardiology 46:10, pages 100910.
Crossref
Crossref
Sophiko Erbel-Khurtsidze, Rainer Seibel, Detlef Moka, Katja Brandt-Mainz, Raimund Erbel & Artur Lichtenberg. (2021) Kardiale Amyloidose und AortenklappenstenoseCardiac amyloidosis and aortic valve stenosis. Herz 46:5, pages 485-496.
Crossref
Crossref
Tanvir Rahman, Reihaneh C Moghadam, Vikram V Agarwal & Craig K Reiss. (2021) Cardiac amyloidosis: diagnostic challenges and recent advancement in the treatment of transthyretin amyloidosis (ATTR). Oxford Medical Case Reports 2021:8.
Crossref
Crossref
Hani Sabbour, Khwaja Yousuf Hasan, Firas Al Badarin, Haluk Alibazoglu, Andrew L. Rivard, Ingy Romany & Stefano Perlini. (2021) From Clinical Clues to Final Diagnosis: The Return of Detective Work to Clinical Medicine in Cardiac Amyloidosis. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Roxana Cristina Rimbas, Anca Balinisteanu, Alexandra Maria Chitroceanu & Dragos Vinereanu. (2021) Cardiac Amyloidosis – An Underdiagnosed Cause of Heart Failure with Preserved Ejection Fraction – Updated Diagnosis and Treatment Options. Romanian Journal of Cardiology 31:2, pages 283-302.
Crossref
Crossref
P. Eldhagen, S. Berg, L.H. Lund, P. Sörensson, O.B. Suhr & P. Westermark. (2021) Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis. Journal of Internal Medicine 289:6, pages 895-905.
Crossref
Crossref
Florint Kroi, Nils Fischer, Ana Gezin, Mahmoud Hashim & Mark Hermannes Rozenbaum. (2020) Estimating the Gender Distribution of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: A Systematic Review and Meta-Analysis. Cardiology and Therapy 10:1, pages 41-55.
Crossref
Crossref
Gabriela Spencer-Bonilla, Joyce N. Njoroge, Keon Pearson, Ronald M. Witteles, Mandar A. Aras & Kevin M. Alexander. (2021) Racial and Ethnic Disparities in Transthyretin Cardiac Amyloidosis. Current Cardiovascular Risk Reports 15:6.
Crossref
Crossref
Dafang Zhang, Melvin C. Makhni, James D. Kang & Philip Blazar. (2021) Orthopaedic Manifestations of Amyloidosis. Journal of the American Academy of Orthopaedic Surgeons 29:10, pages e488-e496.
Crossref
Crossref
Ahsan Huda, Adam Castaño, Anindita Niyogi, Jennifer Schumacher, Michelle Stewart, Marianna Bruno, Mo Hu, Faraz S. Ahmad, Rahul C. Deo & Sanjiv J. Shah. (2021) A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy. Nature Communications 12:1.
Crossref
Crossref
Rabah Alreshq & Frederick L. Ruberg. (2021) Clinical approach to genetic testing in amyloid cardiomyopathy: from mechanism to effective therapies. Current Opinion in Cardiology 36:3, pages 309-317.
Crossref
Crossref
Lily K. Stern & Michelle M. Kittleson. (2021) Updates in Cardiac Amyloidosis Diagnosis and Treatment. Current Oncology Reports 23:4.
Crossref
Crossref
Pablo Garcia-Pavia, Fernando Domínguez & Esther Gonzalez-Lopez. (2021) Amiloidosis cardíaca por transtiretina. Medicina Clínica 156:3, pages 126-134.
Crossref
Crossref
Pablo Garcia-Pavia, Fernando Domínguez & Esther Gonzalez-Lopez. (2021) Transthyretin amyloid cardiomyopathy. Medicina Clínica (English Edition) 156:3, pages 126-134.
Crossref
Crossref
Austin E. Wininger, Brian M. Phelps, Jessica T. Le, Joshua D. Harris, Barry H. Trachtenberg & Shari R. Liberman. (2021) Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery. BMC Musculoskeletal Disorders 22:1.
Crossref
Crossref
Elżbieta Wieczorek, Sylwia Kędracka-Krok, Dominika Bystranowska, Maciej Ptak, Karolina Wiak, Zofia Wygralak, Urszula Jankowska & Andrzej Ożyhar. (2021) Destabilisation of the structure of transthyretin is driven by Ca2+. International Journal of Biological Macromolecules 166, pages 409-423.
Crossref
Crossref
Cindy Varga, Sharmila Dorbala, Isabelle Lousada, Michael J. Polydefkis, Ashutosh Wechalekar, Mathew S. Maurer & Raymond L. Comenzo. (2021) The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main types. Blood Reviews 45, pages 100720.
Crossref
Crossref
M. Grandis, L. Obici, M. Luigetti, C. Briani, F. Benedicenti, G. Bisogni, M. Canepa, F. Cappelli, C. Danesino, G. M. Fabrizi, S. Fenu, G. Ferrandes, C. Gemelli, F. Manganelli, A. Mazzeo, L. Melchiorri, F. Perfetto, L. G. Pradotto, P. Rimessi, G. Tini, S. Tozza, L. Trevisan, D. Pareyson & P. Mandich. (2020) Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Morie Gertz, David Adams, Yukio Ando, João Melo Beirão, Sabahat Bokhari, Teresa Coelho, Raymond L. Comenzo, Thibaud Damy, Sharmila Dorbala, Brian M. Drachman, Marianna Fontana, Julian D. Gillmore, Martha Grogan, Philip N. Hawkins, Isabelle Lousada, Arnt V. Kristen, Frederick L. Ruberg, Ole B. Suhr, Mathew S. Maurer, Jose Nativi-Nicolau, Candida Cristina Quarta, Claudio Rapezzi, Ronald Witteles & Giampaolo Merlini. (2020) Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. BMC Family Practice 21:1.
Crossref
Crossref
Haruki Koike & Masahisa Katsuno. (2020) Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies. Neurology and Therapy 9:2, pages 317-333.
Crossref
Crossref
Gabriela Spencer-Bonilla, Kevin M. Alexander & Ronald M. Witteles. (2020) Advances in the Diagnosis and Management of Transthyretin Amyloid Cardiomyopathy. Current Treatment Options in Cardiovascular Medicine 22:11.
Crossref
Crossref
Todd McVeigh & Carolina Tennyson. (2020) Understanding and recognizing cardiac amyloidosis. JAAPA 33:10, pages 16-20.
Crossref
Crossref
Keith M. George, Richard S. Dowd, Jayde Nail, Anthony Yu, Michael Mastroianni, Andy Y. Wang, Knarik Arkun, Ayan Patel, James Kryzanski, Raymond Comenzo & Ron I. Riesenburger. (2020) Wild-Type Transthyretin Amyloidosis Occurring in the Ligamentum Flavum of the Cervicothoracic Spine. World Neurosurgery 142, pages e325-e330.
Crossref
Crossref
Daria M. Adamczak, Mary-Tiffany Oduah, Thomas Kiebalo, Sonia Nartowicz, Marcin Bęben, Mateusz Pochylski, Aleksandra Ciepłucha, Adrian Gwizdała, Maciej Lesiak & Ewa Straburzyńska-Migaj. (2020) Heart Failure with Preserved Ejection Fraction—a Concise Review. Current Cardiology Reports 22:9.
Crossref
Crossref
Chao Sun, Han Zhang, Xiang Wang & Xinhui Liu. (2020) Ligamentum flavum fibrosis and hypertrophy: Molecular pathways, cellular mechanisms, and future directions. The FASEB Journal 34:8, pages 9854-9868.
Crossref
Crossref
Michelle M. Kittleson, Mathew S. Maurer, Amrut V. Ambardekar, Renee P. Bullock-Palmer, Patricia P. Chang, Howard J. Eisen, Ajith P. Nair, Jose Nativi-Nicolau & Frederick L. Ruberg. (2020) Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association. Circulation 142:1.
Crossref
Crossref
F.J. de Haro-del Moral, V. Pubul-Núñez, I. Casáns-Tormo, A. Jiménez-Heffernan & R. Ruano-Pérez. (2020) Cardiac scintigraphy with 99mTc-diphosphonates in cardiac amyloidosis. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 39:4, pages 254-266.
Crossref
Crossref
F.J. de Haro-del Moral, V. Pubul-Núñez, I. Casáns-Tormo, A. Jiménez-Heffernan & R. Ruano-Pérez. (2020) Gammagrafía cardíaca con 99mTc-difosfonatos en la amiloidosis cardíaca. Revista Española de Medicina Nuclear e Imagen Molecular 39:4, pages 254-266.
Crossref
Crossref
Adam S. Hafeez & Anthony A. Bavry. (2020) Diagnosis of Transthyretin Amyloid Cardiomyopathy. Cardiology and Therapy 9:1, pages 85-95.
Crossref
Crossref
Andrew J. Einstein, Igor Shuryak, Adam Castaño, Akiva Mintz, Mathew S. Maurer & Sabahat Bokhari. (2018) Estimating cancer risk from 99mTc pyrophosphate imaging for transthyretin cardiac amyloidosis. Journal of Nuclear Cardiology 27:1, pages 215-224.
Crossref
Crossref
Elissa Driggin & Mathew S. Maurer. (2019) The quintessential form of diastolic heart failure in older adults: Wild type transthyretin cardiac amyloidosis. Clinical Cardiology 43:2, pages 171-178.
Crossref
Crossref
Jonah RubinMathew S. Maurer. (2020) Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable. Annual Review of Medicine 71:1, pages 203-219.
Crossref
Crossref
Stephanie A. Planque, Richard J. Massey & Sudhir Paul. (2020) Catalytic antibody (catabody) platform for age-associated amyloid disease: From Heisenberg’s uncertainty principle to the verge of medical interventions. Mechanisms of Ageing and Development 185, pages 111188.
Crossref
Crossref
Adam Castaño & Mathew S. Maurer. 2020. Heart Failure: a Companion to Braunwald's Heart Disease. Heart Failure: a Companion to Braunwald's Heart Disease
301
310.e3
.
Sandra Ihne, Caroline Morbach, Laura Obici, Giovanni Palladini & Stefan Störk. (2019) Amyloidosis in Heart Failure. Current Heart Failure Reports 16:6, pages 285-303.
Crossref
Crossref
Fabian aus dem Siepen, Selina Hein, Sofie Prestel, Christian Baumgärtner, Stefan Schönland, Ute Hegenbart, Christoph Röcken, Hugo A. Katus & Arnt V. Kristen. (2019) Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?. Clinical Research in Cardiology 108:12, pages 1324-1330.
Crossref
Crossref
Hiroyuki Yamamoto & Tomoki Yokochi. (2019) Transthyretin cardiac amyloidosis: an update on diagnosis and treatment. ESC Heart Failure 6:6, pages 1128-1139.
Crossref
Crossref
Richard S. Dowd, T. Jayde Nail, Knarik Arkun, James Kryzanski, Oscar Soto, Teresa Fogaren, Kelly Harrington, Ayan Patel, Raymond Comenzo & Ron I. Riesenburger. (2019) Where Neurosurgery Meets Heart Failure: A Case Report of a Patient with Amyloid Transthyretin Wild Type in the Ligamentum Flavum and Cardiac Tissue with Bilateral Carpal Tunnel Syndrome. World Neurosurgery 131, pages 104-107.
Crossref
Crossref
Mathew S. MaurerSabahat BokhariThibaud DamySharmila DorbalaBrian M. DrachmanMarianna FontanaMartha GroganArnt V. KristenIsabelle LousadaJose Nativi-NicolauCandida Cristina QuartaClaudio RapezziFrederick L. RubergRonald WittelesGiampaolo Merlini. (2019) Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. Circulation: Heart Failure 12:9.
Crossref
Crossref
Kourosh Rezania & Laleh Saadat. 2019. Amyloid Diseases. Amyloid Diseases.
Ronald M. Witteles, Sabahat Bokhari, Thibaud Damy, Perry M. Elliott, Rodney H. Falk, Nowell M. Fine, Mariana Gospodinova, Laura Obici, Claudio Rapezzi & Pablo Garcia-Pavia. (2019) Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice. JACC: Heart Failure 7:8, pages 709-716.
Crossref
Crossref
Frederick L. Ruberg, Martha Grogan, Mazen Hanna, Jeffery W. Kelly & Mathew S. Maurer. (2019) Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology 73:22, pages 2872-2891.
Crossref
Crossref
A.S. Carr, S. Shah, D. Choi, J. Blake, R. Phadke, J. Gilbertson, C.J. Whelan, A.D. Wechalekar, J.D. Gillmore, P.N. Hawkins & M.M. Reilly. (2019) Spinal Stenosis in Familial Transthyretin Amyloidosis. Journal of Neuromuscular Diseases 6:2, pages 267-270.
Crossref
Crossref
Mathew Maurer & Adam Castaño. (2019) Prognosticating in Cardiac Amyloidosis. JACC: Cardiovascular Imaging 12:5, pages 834-836.
Crossref
Crossref
Haruki Koike & Masahisa Katsuno. (2019) Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights. Biomedicines 7:1, pages 11.
Crossref
Crossref
Elżbieta Wieczorek, Anna Chitruń & Andrzej Ożyhar. (2019) Destabilised human transthyretin shapes the morphology of calcium carbonate crystals. Biochimica et Biophysica Acta (BBA) - General Subjects 1863:2, pages 313-324.
Crossref
Crossref
Mathew S. Maurer & Frederick L. Ruberg. (2018) Early Diagnosis of Cardiac Amyloidosis by Carpal Tunnel Surgery. Journal of the American College of Cardiology 72:17, pages 2051-2053.
Crossref
Crossref
Jose Nativi-Nicolau & Mathew S. Maurer. (2018) Amyloidosis cardiomyopathy. Current Opinion in Cardiology 33:5, pages 571-579.
Crossref
Crossref
Mathew S. Maurer, Frederick L. Ruberg & Jonathan W. Weinsaft. (2018) More Than Meets the Eye: Time for a New Imaging Paradigm to Test for Cardiac Amyloidosis. Journal of Cardiac Failure 24:2, pages 87-89.
Crossref
Crossref
Yaser Nemshah, Alex Clavijo & Gyanendra Sharma. (2018) Amyloid Heart Disease. US Cardiology Review 12:2, pages 113.
Crossref
Crossref
Gunilla T. Westermark, Marcus Fändrich, Katarzyna Lundmark & Per Westermark. (2018) Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission. Cold Spring Harbor Perspectives in Medicine 8:1, pages a024323.
Crossref
Crossref
Meenakshi Mukherjee, Jeryl C. Jones & Jianbo Yao. (2017) Lumbosacral stenosis in Labrador retriever military working dogs – an exomic exploratory study. Canine Genetics and Epidemiology 4:1.
Crossref
Crossref
Sofía Calero Núñez, Antonia Tercero Martínez, Juan Carlos García López & Jesús Jiménez-Mazuecos. (2017) Amiloidosis cardiaca senil y estenosis aórtica degenerativa: 2 enfermedades interrelacionadas en el anciano. Revista Española de Geriatría y Gerontología 52:3, pages 167-170.
Crossref
Crossref
O. B. Suhr, E. Lundgren & P. Westermark. (2017) One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition. Journal of Internal Medicine 281:4, pages 337-347.
Crossref
Crossref
Natalie J. Galant, Per Westermark, Jeffrey N. HigakiAvijit Chakrabartty. (2017) Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy. Clinical Science 131:5, pages 395-409.
Crossref
Crossref
Ville V. Meretoja, Sudhir Paul & Stephanie A. Planque. 2017. Natural Antibodies. Natural Antibodies
111
134
.
Danielle L. Brunjes, Adam Castano, Autumn Clemons, Jonah Rubin & Mathew S. Maurer. (2016) Transthyretin Cardiac Amyloidosis in Older Americans. Journal of Cardiac Failure 22:12, pages 996-1003.
Crossref
Crossref
Hacer Durmuş-Tekçe, Zeliha Matur, Murat Mert Atmaca, Mehves Poda, Arman Çakar, Ümit Hıdır Ulaş, Piraye Oflazer-Serdaroğlu, Feza Deymeer & Yesim G. Parman. (2016) Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey. Neuromuscular Disorders 26:7, pages 441-446.
Crossref
Crossref
Natalie J. Galant, Antoinette Bugyei-Twum, Rishi Rakhit, Patrick Walsh, Simon Sharpe, Pharhad Eli Arslan, Per Westermark, Jeffrey N. Higaki, Ronald Torres, José Tapia & Avijit Chakrabartty. (2016) Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses. Scientific Reports 6:1.
Crossref
Crossref
Irina Iakovleva, Kristoffer Brännström, Lina Nilsson, Anna L. Gharibyan, Afshan Begum, Intissar Anan, Malin Walfridsson, A. Elisabeth Sauer-Eriksson & Anders Olofsson. (2015) Enthalpic Forces Correlate with the Selectivity of Transthyretin-Stabilizing Ligands in Human Plasma. Journal of Medicinal Chemistry 58:16, pages 6507-6515.
Crossref
Crossref
K. S. Patel & P. N. Hawkins. (2015) Cardiac amyloidosis: where are we today?. Journal of Internal Medicine 278:2, pages 126-144.
Crossref
Crossref
Urban Hellman, Hans-Erik Lundgren, Per Westermark, Christina Stafberg, Hareth Nahi, Sascha Tachlinski, Michael Guggi, Max Flogegård, Mehmet Hamid, Stefan A. Escher & Ole B. Suhr. (2015) A genealogical and clinical study of the phenotypical variation within the Swedish transthyretin His88Arg (p. His108Arg) amyloidosis family. European Journal of Medical Genetics 58:4, pages 211-215.
Crossref
Crossref
Akihiro Yanagisawa, Mitsuharu Ueda, Takanao Sueyoshi, Tatsuya Okada, Toru Fujimoto, Yasuhiro Ogi, Keisuke Kitagawa, Masayoshi Tasaki, Yohei Misumi, Toshinori Oshima, Hirofumi Jono, Konen Obayashi, Kei Hirakawa, Hitoshi Uchida, Per Westermark, Yukio Ando & Hiroshi Mizuta. (2015) Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis. Modern Pathology 28:2, pages 201-207.
Crossref
Crossref
Per Westermark. 2015. Amyloid and Related Disorders. Amyloid and Related Disorders
95
120
.
Mario Nuvolone, Giovanni Palladini & Giampaolo Merlini. 2015. Amyloid and Related Disorders. Amyloid and Related Disorders
9
29
.